These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21514852)

  • 1. Local delivery strategies in epilepsy: a focus on adenosine.
    Van Dycke A; Raedt R; Vonck K; Boon P
    Seizure; 2011 Jun; 20(5):376-82. PubMed ID: 21514852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous local intrahippocampal delivery of adenosine reduces seizure frequency in rats with spontaneous seizures.
    Van Dycke A; Raedt R; Dauwe I; Sante T; Wyckhuys T; Meurs A; Vonck K; Wadman W; Boon P
    Epilepsia; 2010 Sep; 51(9):1721-8. PubMed ID: 20726873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies.
    Boison D
    Neuroscientist; 2005 Feb; 11(1):25-36. PubMed ID: 15632276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of protein and gene medicines through the blood-brain barrier.
    Pardridge WM
    Clin Pharmacol Ther; 2015 Apr; 97(4):347-61. PubMed ID: 25669455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential new methods for antiepileptic drug delivery.
    Fisher RS; Ho J
    CNS Drugs; 2002; 16(9):579-93. PubMed ID: 12153331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts.
    Güttinger M; Padrun V; Pralong WF; Boison D
    Exp Neurol; 2005 May; 193(1):53-64. PubMed ID: 15817264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine kinase, epilepsy and stroke: mechanisms and therapies.
    Boison D
    Trends Pharmacol Sci; 2006 Dec; 27(12):652-8. PubMed ID: 17056128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory epilepsy: mechanisms and solutions.
    Kwan P; Brodie MJ
    Expert Rev Neurother; 2006 Mar; 6(3):397-406. PubMed ID: 16533143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation.
    Boison D; Stewart KA
    Biochem Pharmacol; 2009 Dec; 78(12):1428-37. PubMed ID: 19682439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 1 - Drug delivery to the brain using colloidal carriers.
    Chang J; Jallouli Y; Barras A; Dupont N; Betbeder D
    Prog Brain Res; 2009; 180():2-17. PubMed ID: 20302826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly organized nanostructures for brain drug delivery--new hope or just a fad?
    Labuzek K; Gorki K; Jaroszek H; Jarzabek K; Gabryel B; Okopien B
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1271-85. PubMed ID: 24040789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug development in Parkinson's disease: from emerging molecules to innovative drug delivery systems.
    Garbayo E; Ansorena E; Blanco-Prieto MJ
    Maturitas; 2013 Nov; 76(3):272-8. PubMed ID: 23827471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal treatment for refractory epilepsy: hope for the future?
    Nilsen KE; Cock HR
    Brain Res Brain Res Rev; 2004 Mar; 44(2-3):141-53. PubMed ID: 15003390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium channels: brief overview and implications in epilepsy.
    Benarroch EE
    Neurology; 2009 Feb; 72(7):664-9. PubMed ID: 19221301
    [No Abstract]   [Full Text] [Related]  

  • 16. Chapter 3 - Colloidal systems for CNS drug delivery.
    Costantino L; Tosi G; Ruozi B; Bondioli L; Vandelli MA; Forni F
    Prog Brain Res; 2009; 180():35-69. PubMed ID: 20302828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal delivery of biologics to the central nervous system.
    Lochhead JJ; Thorne RG
    Adv Drug Deliv Rev; 2012 May; 64(7):614-28. PubMed ID: 22119441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigabatrin for focal drug delivery in epilepsy: bilateral microinfusion into the subthalamic nucleus is more effective than intranigral or systemic administration in a rat seizure model.
    Bröer S; Backofen-Wehrhahn B; Bankstahl M; Gey L; Gernert M; Löscher W
    Neurobiol Dis; 2012 May; 46(2):362-76. PubMed ID: 22342648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches.
    Potschka H
    Pharmacogenomics; 2010 Oct; 11(10):1427-38. PubMed ID: 21047204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier.
    Krol S; Macrez R; Docagne F; Defer G; Laurent S; Rahman M; Hajipour MJ; Kehoe PG; Mahmoudi M
    Chem Rev; 2013 Mar; 113(3):1877-903. PubMed ID: 23157552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.